Effective treatment for moderate to severe plaque psoriasis (PsO) is a critical medical need. Certolizumab pegol (CZP), a novel therapeutic option, has shown promise. A retrospective observational study published in Farmacia Hospitalaria...
Effective treatment for moderate to severe plaque psoriasis (PsO) is a critical medical need. Certolizumab pegol (CZP), a novel therapeutic option, has shown promise. A retrospective observational study published in Farmacia Hospitalaria...
In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...
In this interview, Dr Sadick explores cutting-edge advancements in regenerative medicine, including PRP, exosomes, and cell banking, and their potential to revolutionize dermatology. Key insights are provided on emerging technologies and...
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate cardiovascular risk in Slovak patients with psoriasis and investigate the relationship between cardiovascular risk and psoriasis features.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
Researchers aimed to evaluate serum levels of inflammatory cytokines, specifically tumor necrosis factor-alpha and IL-17, in patients with nail psoriasis.
